» Articles » PMID: 37151879

Bulk and Single-cell Transcriptome Profiling Reveal Extracellular Matrix Mechanical Regulation of Lipid Metabolism Reprograming Through YAP/TEAD4/ACADL Axis in Hepatocellular Carcinoma

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2023 May 8
PMID 37151879
Authors
Affiliations
Soon will be listed here.
Abstract

Emerging studies have revealed matrix stiffness promotes hepatocellular carcinoma (HCC) development. We studied metabolic dysregulation in HCC using the TCGA-LIHC database (n=374) and GEO datasets (GSE14520). HCC samples were classified into three heterogeneous metabolic pathway subtypes with different metabolic profiles: Cluster 1, an ECM-producing subtype with upregulated glycan metabolism; Cluster 2, a hybrid subtype with partial pathway dysregulation. Cluster 3, a lipogenic subtype with upregulated lipid metabolism; These three subtypes have different prognosis, clinical features and genomic alterations. We identified key enzymes that respond to matrix stiffness and regulate lipid metabolism through bioinformatic analysis. We found long-chain acyl-CoA dehydrogenase (ACADL) is a mechanoreactive enzyme that reprograms HCC cell lipid metabolism in response to extracellular matrix stiffness. ACADL is also regarded as tumor suppressor in HCC. We found that increased extracellular matrix stiffness led to activation of Yes-associated protein (YAP) and the YAP/TEA Domain transcription factor 4 (TEAD4) transcriptional complex was able to directly repress ACADL at the transcriptional level. The ACADL-dependent mechanoresponsive pathway is a potential therapeutic target for HCC treatment.

Citing Articles

Huqi formula suppresses hepatocellular carcinoma growth by modulating the PI3K/AKT/mTOR pathway and promoting T cell infiltration.

Yin D, Li X, Yang X, Shang X, Li Z, Geng J Chin Med. 2025; 20(1):25.

PMID: 39972480 PMC: 11837637. DOI: 10.1186/s13020-025-01061-w.


Matrix stiffness regulates nucleus pulposus cell glycolysis by MRTF-A-dependent mechanotransduction.

Xu H, Wei K, Ni J, Deng X, Wang Y, Xiang T Bone Res. 2025; 13(1):23.

PMID: 39952914 PMC: 11828926. DOI: 10.1038/s41413-025-00402-7.


The Multifaced Role of Collagen in Cancer Development and Progression.

Lo Buglio G, Lo Cicero A, Campora S, Ghersi G Int J Mol Sci. 2025; 25(24.

PMID: 39769286 PMC: 11678882. DOI: 10.3390/ijms252413523.


Long noncoding RNA LINC01106 promotes lung adenocarcinoma progression via upregulation of autophagy.

Sun G, Zheng Y, Cai J, Gao J, Dong L, Zhang X Oncol Res. 2024; 33(1):171-184.

PMID: 39735666 PMC: 11671404. DOI: 10.32604/or.2024.047626.


Synergistic Anticancer Strategy Targeting ECM Stiffness: Integration of Matrix Softening and Mechanical Signal Transduction Blockade in Primary Liver Cancers.

Shen Z, Tao L, Wang Y, Zhu Y, Pan H, Li Y Adv Sci (Weinh). 2024; 12(6):e2403040.

PMID: 39703167 PMC: 11809367. DOI: 10.1002/advs.202403040.


References
1.
Levental K, Yu H, Kass L, Lakins J, Egeblad M, Erler J . Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 2009; 139(5):891-906. PMC: 2788004. DOI: 10.1016/j.cell.2009.10.027. View

2.
Vining K, Mooney D . Mechanical forces direct stem cell behaviour in development and regeneration. Nat Rev Mol Cell Biol. 2017; 18(12):728-742. PMC: 5803560. DOI: 10.1038/nrm.2017.108. View

3.
Elosegui-Artola A, Andreu I, Beedle A, Lezamiz A, Uroz M, Kosmalska A . Force Triggers YAP Nuclear Entry by Regulating Transport across Nuclear Pores. Cell. 2017; 171(6):1397-1410.e14. DOI: 10.1016/j.cell.2017.10.008. View

4.
Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

5.
Huang D, Li T, Li X, Zhang L, Sun L, He X . HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. Cell Rep. 2014; 8(6):1930-1942. DOI: 10.1016/j.celrep.2014.08.028. View